We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$75.2M
2
LOXO
Loxo Oncology, Inc
LOXO
+$28.1M
3
DHR icon
Danaher
DHR
+$27.9M
4
A icon
Agilent Technologies
A
+$26.4M
5
MKC icon
McCormick & Company Non-Voting
MKC
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRSH
301
Marsh
MRSH
$87.5B
$5.53M 0.07%
58,920
-8,616
-13% -$762K
SPG icon
302
Simon Property Group
SPG
$75.1B
$5.51M 0.07%
27,222
+1,424
+6% +$253K
WMB icon
303
Williams Companies
WMB
$86.6B
$5.39M 0.07%
187,764
-175,277
-48% -$4.7M
BNY
304
Bank of New York Mellon
BNY
$107B
$5.39M 0.07%
106,889
+1,668
+2% +$86K
CM icon
305
Canadian Imperial Bank of Commerce
CM
$108B
$5.37M 0.07%
135,900
-45,576
-25% -$1.89M
DISCK
306
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$5.35M 0.07%
210,432
+162,076
+335% +$4.24M
SYY icon
307
Sysco
SYY
$40.2B
$5.33M 0.07%
63,932
+3,797
+6% +$247K
CMI icon
308
Cummins
CMI
$91.3B
$5.32M 0.07%
33,663
-47,645
-59% -$7.15M
APC
309
DELISTED
Anadarko Petroleum
APC
$5.29M 0.07%
116,400
+5,964
+5% +$270K
HSY icon
310
Hershey
HSY
$36.6B
$5.2M 0.07%
24,274
+1,543
+7% +$168K
MDGL icon
311
Madrigal Pharmaceuticals
MDGL
$12.7B
$5.19M 0.07%
41,450
+10,000
+32% +$1.24M
K
312
DELISTED
Kellanova
K
$5.18M 0.07%
96,211
-13,494
-12% -$720K
VFC icon
313
VF Corp
VFC
$6.72B
$5.14M 0.07%
62,842
-22,694
-27% -$1.77M
BHBK
314
DELISTED
Blue Hills Bancorp, Inc.
BHBK
$5.14M 0.07%
215,007
+37,344
+21% +$877K
TIF
315
DELISTED
Tiffany & Co.
TIF
$5.12M 0.07%
48,527
-106,458
-69% -$9.77M
ITW icon
316
Illinois Tool Works
ITW
$81.9B
$5.12M 0.07%
35,645
-37,009
-51% -$5.12M
ANAB icon
317
AnaptysBio
ANAB
$1.59B
$5.11M 0.07%
70,000
– –
GPN icon
318
Global Payments
GPN
$23B
$5.05M 0.06%
37,007
+23,893
+182% +$2.9M
BNS icon
319
Scotiabank
BNS
$106B
$5.04M 0.06%
94,727
-9,826
-9% -$538K
TRCO
320
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$5.04M 0.06%
109,250
+59,250
+119% +$2.73M
DRI icon
321
Darden Restaurants
DRI
$23.4B
$5.04M 0.06%
41,491
+23,128
+126% +$2.54M
BFH icon
322
Bread Financial
BFH
$4.29B
$5.04M 0.06%
36,066
+7,841
+28% +$1.07M
ULTI
323
DELISTED
Ultimate Software Group Inc
ULTI
$5.02M 0.06%
15,200
+2,984
+24% +$915K
VNDA icon
324
Vanda Pharmaceuticals
VNDA
$314M
$4.99M 0.06%
271,000
+93,000
+52% +$2.12M
MTB icon
325
M&T Bank
MTB
$36B
$4.94M 0.06%
31,432
+16,377
+109% +$2.69M
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.